Preclinical efficacy of a HER2 synNotch/CEA-CAR combinatorial immunotherapy against colorectal cancer with HER2 amplification
2024 · Molecular Therapy · 24 citations
https://doi.org/10.1016/j.ymthe.2024.06.023
C
Chiara Donini
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
86
Papers
398
Citations
11
h-index
12
i10-index
Chiara Donini is an academic researcher. The author has contributed to research in topics: CAR-T cell therapy research & Sarcoma Diagnosis and Treatment & Cancer Immunotherapy and Biomarkers. The author has an h-index of 11, co-authored 74 publications.
ORCID: 0000-0003-1988-9762Papers by this author
worksEfficacy of CAR-T immunotherapy in MET overexpressing tumors not eligible for anti-MET targeted therapy
2022 · Journal of Experimental & Clinical Cancer Research · 18 citations
https://doi.org/10.1186/s13046-022-02479-y
Novel Lymphocyte-Independent Antitumor Activity by PD-1 Blocking Antibody against PD-1+ Chemoresistant Lung Cancer Cells
2022 · Clinical Cancer Research · 16 citations
https://doi.org/10.1158/1078-0432.ccr-22-0761
Development and activity of canine B7-H3-CAR.CIK lymphocytes against sarcomas: preclinical evidence and perspectives for human clinical translation
2025 · Cancer Immunology Immunotherapy · 0 citations
https://doi.org/10.1007/s00262-025-04163-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat